Dopaminergic regulation of striatal ensembles during cognitive performance: Implications for Parkinson's disease
Dopaminergic regulation of striatal ensembles during cognitive performance: Implications for Parkinson's disease
批准号:
9816572
负责人:
Benjamin DeCorte
金额:
$3.13万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-02-16 至 2020-02-15
关键词:
AffectAgeAnimal Disease ModelsAnimal ModelAttentionBehaviorBehavioral AssayCognitionCognitive deficitsCorpus striatum structureCuesDataDecision MakingDiseaseDopamineDopamine D1 ReceptorDopamine D2 ReceptorDopamine ReceptorElectrophysiology (science)EmploymentFundingHumanImpaired cognitionImpairmentIndividualKnowledgeLateralMalignant - descriptorMediatingMemoryMotorMovementNeurobehavioral ManifestationsNeuronsNursing HomesOutputParkinson DiseasePatientsPatternPerformancePharmacologyPlayPopulationPrevalenceRampRegulationRodentRoleScientistShort-Term MemoryStructureSubstantia nigra structureSymptomsTechniquesTestingTimeTrainingWorkbasecareercell typecognitive functioncognitive performancecognitive taskdisabling symptomdopaminergic neuroneffective therapyinsightmotor impairmentmotor symptomnervous system disorderneural circuitneuronal cell bodynovel therapeuticsoptogeneticspars compactapreservationpreventrecruitresponsetime interval
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
Patients with Parkinson's disease suffer from debilitating motor and cognitive
impairments. These symptoms are largely driven by the striatal dopamine depletion caused by
the disease. In healthy individuals, striatal dopamine modulates distinct pools of medium striatal
spiny neurons (MSNs) that express either D1 or D2 receptors. D1 and D2 MSNs project to
different downstream structures and play dissociable roles in movement. However, how D1 and
D2 MSNs mediate higher-order cognitive functions is unclear. This proposal will target this
knowledge gap by investigating how D1 and D2 MSNs mediate performance during timing
tasks. During timing tasks, subjects are presented with a cue that informs them to make a motor
response after a certain interval of time elapses (e.g., press a button after 6 seconds passes).
Timing tasks recruit several cognitive functions (e.g., working-memory, attention, and decision-
making). Furthermore, timing is heavily dependent on the striatum, sensitive to dopaminergic
manipulations, and disrupted in both Parkinson's patients and animal models of this disease.
In Aim 1, we will evaluate how striatal dopamine modulates D1 and D2 MSN activity
during timing tasks. Specifically, during timing tasks, many MSNs progressively increase or
decrease their firing rates linearly across time. This `ramping' activity is critical for performance
and appears to progress until a `threshold' level of activity is reached, at which point a decision
to respond is made. Blocking striatal D1 or D2 receptors delays when decisions are made
during timing tasks. Furthermore, the types of decisions that are impacted by D1 or D2 blockade
are dissociable. We will combine focal pharmacology, cell-type specific optogenetics, and
electrophysiology to test the hypothesis that dopamine tunes the threshold activity level of D1
and D2 ramping MSNs. In Aim 2, we will test the hypothesis that local connectivity between D1
and D2 MSNs within the striatum is critical for timing performance. Specifically, blocking striatal
D2 receptors substantially impairs timing behavior. Surprisingly, inactivating the downstream
structures of D2 MSNs does not impact timing performance. Therefore, we will test the
hypothesis that D2 MSNs mediate timing via lateral inhibition to D1 MSNs within the striatum,
rather than through their downstream output. Specifically, we will disrupt D2 MSN activity while
simultaneously blocking the downstream output of D2 MSNs with optogenetics. If D2 MSNs
mediate timing via lateral inhibition within the striatum, manipulating D2 MSN activity within the
striatum should still exert an effect, even when their downstream output is blocked.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: